You are here


Taking a new path in pain management (Amended)

iX Biopharma wants to be the first in the world to get ketamine registered in the US as an alternative to opioid - the only pain management drug administered by doctors.

"The Singapore Economic Development Board has spent years bringing the big pharmas to have manufacturing plants here. That means the day I'm ready to get my products registered and when we need to market, Singapore is ready for me." - Mr Lee


WITH one day to go before it trades on the Catalist, late-stage specialty pharmaceutical firm iX Biopharma has already caught the eyes of interested parties.

This might have something to do with the firm's niche, which lies in the development and commercialisation of